Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127802391 | 12780239 | 1 | I | 20160914 | 20160926 | 20160926 | PER | US-ASTRAZENECA-2016SE98406 | ASTRAZENECA | 0.00 | F | Y | 93.40000 | KG | 20160926 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127802391 | 12780239 | 1 | PS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | 90 MCG 165 MG. 2 PUFFS PER DAY | U | U | 20929 | INHALATION POWDER | |||||||
| 127802391 | 12780239 | 2 | C | XARELTO | RIVAROXABAN | 1 | Oral | 0 | 25 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127802391 | 12780239 | 1 | Asthma |
| 127802391 | 12780239 | 2 | Atrial fibrillation |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127802391 | 12780239 | Drug dose omission | |
| 127802391 | 12780239 | Dyspnoea | |
| 127802391 | 12780239 | Insomnia | |
| 127802391 | 12780239 | Nasopharyngitis | |
| 127802391 | 12780239 | Off label use | |
| 127802391 | 12780239 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |